$306.95
1.180.39%
At close: -
$305.00
-1.95-0.64%
After Hours: 4:42 PM EDT
Comments
Loading...
Amgen Stock Guidance | NASDAQ:AMGN | Benzinga
Amgen issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/04/2025 | AMGN | Amgen | FY | 2025 | $20.00 | $21.20 | $20.82 | $34.30B | $35.70B | $34.53B | Get Alert |
| 10/30/2024 | AMGN | Amgen | FY | 2024 | $19.20 | $20.00 | $19.49 | $33.00B | $33.80B | $33.21B | Get Alert |
| 08/06/2024 | AMGN | Amgen | FY | 2024 | $19.10 | $20.10 | $17.87 | $32.80B | $33.80B | $30.30B | Get Alert |
| 05/02/2024 | AMGN | Amgen | FY | 2024 | $19.00 | $20.20 | $19.48 | $32.50B | $33.80B | $32.95B | Get Alert |
| 02/06/2024 | AMGN | Amgen | FY | 2024 | $18.90 | $20.30 | $20.00 | $32.40B | $33.80B | $32.66B | Get Alert |
| 10/31/2023 | AMGN | Amgen | FY | 2023 | $18.20 | $18.80 | $17.31 | $28.00B | $28.40B | $25.99B | Get Alert |
| 08/03/2023 | AMGN | Amgen | FY | 2023 | $17.80 | $18.80 | $17.75 | $26.60B | $27.40B | $26.56B | Get Alert |
| 04/27/2023 | AMGN | Amgen | FY | 2023 | $17.60 | $18.70 | $17.72 | $26.20B | $27.30B | $26.70B | Get Alert |
| 01/31/2023 | AMGN | Amgen | FY | 2023 | $17.40 | $18.60 | $17.68 | $26.00B | $27.20B | $26.25B | Get Alert |
| 11/03/2022 | AMGN | Amgen | FY | 2022 | $17.25 | $17.85 | $17.50 | $26.00B | $26.30B | $26.14B | Get Alert |
| 08/04/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.40 | $25.50B | $26.40B | $26.23B | Get Alert |
| 04/27/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.63 | $25.40B | $26.50B | $26.14B | Get Alert |
| 02/08/2022 | AMGN | Amgen | FY | 2022 | $17.00 | $18.00 | $17.83 | — | — | — | Get Alert |
| 11/02/2021 | AMGN | Amgen | FY | 2021 | $16.50 | $17.10 | $16.43 | $25.80B | $26.20B | $26.01B | Get Alert |
| 08/03/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.34 | $25.80B | $26.60B | $26.04B | Get Alert |
| 04/27/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.80 | $25.80B | $26.60B | $26.41B | Get Alert |
| 03/04/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $16.85 | $25.80B | $26.60B | $26.47B | Get Alert |
| 02/02/2021 | AMGN | Amgen | FY | 2021 | $16.00 | $17.00 | $17.02 | $25.80B | $26.60B | $26.43B | Get Alert |
| 10/28/2020 | AMGN | Amgen | FY | 2020 | $15.80 | $16.15 | $15.77 | $25.10B | $25.50B | $25.41B | Get Alert |
| 07/28/2020 | AMGN | Amgen | FY | 2020 | $15.10 | $15.75 | $15.64 | $25.00B | $25.60B | $25.45B | Get Alert |
FAQ
What is the most recent guidance for Amgen (AMGN)?
The most recent guidance for Amgen (AMGN) was reported on February 4, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $20.00 to $21.20, compared to the estimated EPS of $20.82. Additionally, Amgen forecasted revenue between $34.30B and $35.70B for the quarter.
Browse guidance and forecast on all stocks.